当前位置：首页 SCI 期刊 Neuropsychopharmacology Reports(非官网)

Neuropsychopharmacology ReportsSCIE

国际简称：Neuropsychopharmacology Reports 参考译名：神经精神药理学报告

CiteScore分区
Q2
JCR分区
Q3

基本信息：: ISSN：2574-173X; 是否OA：开放; 是否预警：否

出版信息：: 出版地区：Australia; 出版商：Wiley-Blackwell; 出版语言：English; 研究方向：Psychology-Clinical Psychology

评价信息：: 影响因子：2; CiteScore指数：3.6; SJR指数：0.66; SNIP指数：0.65

发文数据：: Gold OA文章占比：74.37%; 研究类文章占比：91.49%; 年发文量：94

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据 JCR分区发文数据常见问题

英文简介Neuropsychopharmacology Reports期刊介绍

Neuropsychopharmacology Reports is a peer-reviewed open access journal focused on the field of neuropsychological pharmacology. This journal aims to rapidly disseminate research findings on neurological function, psychiatry, drug mechanisms of action, and new drug development. The content of the journal covers a wide range of research from basic science to clinical trials, providing an important knowledge exchange platform for researchers, clinical doctors, and other healthcare professionals.

The main readership of this magazine includes neuroscientists, psychiatrists, pharmacologists, clinical doctors, graduate students, and postdoctoral researchers. One of its characteristics is its fast publishing model, which helps researchers quickly share their findings and drive scientific progress in the field. In addition, the journal emphasizes the clinical relevance of research and encourages submission of studies that can directly impact patient care and treatment. Through an open access publishing model, this journal ensures wide accessibility of research findings, promotes scientific collaboration and knowledge dissemination on a global scale.

期刊简介Neuropsychopharmacology Reports期刊介绍

《Neuropsychopharmacology Reports》该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 14 Weeks
SCIE
非预警

Cite Score数据（2024年最新版）Neuropsychopharmacology Reports Cite Score数据

CiteScore：3.6
SJR：0.66
SNIP：0.646

学科类别	分区	排名	百分位
大类：Psychology 小类：Clinical Psychology	Q2	121 / 311	61%
大类：Psychology 小类：Psychiatry and Mental Health	Q2	274 / 567	51%
大类：Psychology 小类：Pharmacology (medical)	Q3	142 / 272	47%
大类：Psychology 小类：Pharmacology	Q3	188 / 313	40%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Neuropsychopharmacology Reports JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：NEUROSCIENCES	ESCI	Q3	228 / 310	26.6%
学科：PHARMACOLOGY & PHARMACY	ESCI	Q3	222 / 354	37.4%
学科：PSYCHIATRY	ESCI	Q3	157 / 276	43.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：NEUROSCIENCES	ESCI	Q4	236 / 310	24.03%
学科：PHARMACOLOGY & PHARMACY	ESCI	Q3	225 / 354	36.58%
学科：PSYCHIATRY	ESCI	Q3	176 / 276	36.41%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

1、Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
Author: Fukumoto, Kentaro; Kodaka, Fumitoshi; Hasegawa, Naomi; Muraoka, Hiroyuki; Hori, Hikaru; Ichihashi, Kayo; Yasuda, Yuka; Iida, Hitoshi; Ohi, Kazutaka; Ochi, Shinichiro; Ide, Kenta; Hashimoto, Naoki; Usami, Masahide; Nakamura, Toshinori; Komatsu, Hiroshi; Okada, Tsuyoshi; Nagasawa, Tatsuya; Furihata, Ryuji; Atake, Kiyokazu; Kido, Mikio; Kikuchi, Saya; Yamagata, Hirotaka; Kishimoto, Taishiro; Makinodan, Manabu; Horai, Tadasu; Takeshima, Masahiro; Kubota, Chika; Asami, Takeshi; Katsumoto, Eiichi; Hishimoto, Akitoyo; Onitsuka, Toshiaki; Matsumoto, Junya; Miura, Kenichiro; Yamada, Hisashi; Yasui-Furukori, Norio; Watanabe, Koichiro; Inada, Ken; Otsuka, Kotaro; Hashimoto, Ryota

Journal: NEUROPSYCHOPHARMACOLOGY REPORTS. 2023; Vol. 43, Issue 1, pp. 33-39. DOI: 10.1002/npr2.12301
2、Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Author: Iida, Hitoshi; Okada, Tsuyoshi; Nemoto, Kiyotaka; Hasegawa, Naomi; Numata, Shusuke; Ogasawara, Kazuyoshi; Miura, Kenichiro; Matsumoto, Junya; Hori, Hikaru; Iga, Jun-ichi; Ichihashi, Kayo; Hashimoto, Naoki; Yamada, Hisashi; Ohi, Kazutaka; Yasui-Furukori, Norio; Fukumoto, Kentaro; Tsuboi, Takashi; Usami, Masahide; Furihata, Ryuji; Takaesu, Yoshikazu; Hishimoto, Akitoyo; Muraoka, Hiroyuki; Katsumoto, Eiichi; Nagasawa, Tatsuya; Ochi, Shinichiro; Komatsu, Hiroshi; Kikuchi, Saya; Takeshima, Masahiro; Onitsuka, Toshiaki; Tamai, Shinichiro; Kubota, Chika; Inada, Ken; Watanabe, Koichiro; Kawasaki, Hiroaki; Hashimoto, Ryota

Journal: NEUROPSYCHOPHARMACOLOGY REPORTS. 2023; Vol. 43, Issue 1, pp. 23-32. DOI: 10.1002/npr2.12300